Population pharmacokinetic and dynamic analysis of the topoisomerase 1 inhibitor lurtotecan in phase I studies

J.H.M. Schellens, B. Heinrich, M. Lehnert, M.E. Gore, S.B. Kaye, P. Dombernowsky, R. Paridaens, A.T. van Oosterom, J. Verweij, W.J. Loos, H. Calvert, N. Pavlidis, H. Cortes-Funes, J. Wanders, M. Roelvink, M.C. Sessa, K. Selinger, P.S. Wissel, T. Gamucci, A.R. Hanauske

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)83-93
Number of pages10
JournalInvestigational New Drugs
Volume20
Publication statusPublished - 2002

Cite this